Searched for
K G ANANTHAKRISHNAN
I-Sec initiates coverage on Suven Pharmaceuticals with a Buy rating, target price Rs 1,400ICICI Securities recommends buying Suven Pharmaceuticals with a target price of Rs 1,400. The firm exhibits strong quarterly growth, report...- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
- Pharma, healthcare industry looks to sustain momentum in 2022Listing out difficulties for the domestic pharma industry, Sun Pharma CEO (India Business) Kirti Ganorkar said that currency fluctuations, ...
- MSD launches medical, healthcare website called 'Univadis'Univadis is an online resource for healthcare professionals launched in 40 countries, available in 17 languages, with 20 mn registered user...
- Cipla to market MSD's HIV drug 'raltegravir' in IndiaMSD in India Managing Director K G Ananthakrishnan said the partnership is aligned with the company's commitment towards patients in India.
- Lupin to market MSD's pneumonia prevention vaccine in IndiaAs part of the agreement promote and distribute MSD's 23-valent Pneumococcal Polysaccharide Vaccine under a different brand name in the cou...
- MSD India to invest $10 million to reduce maternal mortalityMSD for Mothers, drug firm would partner three non-governmental organisations across three states in India- Rajasthan, Jharkhand and Uttar ...
- Merck scouts for marketing, licensing pacts with Indian cosMerck & Co, is looking at in-licensing and co-marketing arrangements with Indian pharma cos as it wants to realise its ambitions to become ...
Load More